-
Start Preamble
Start Printed Page 8099
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel.
Date: March 19, 2009.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: Democracy Plaza II, 6707 Democracy Blvd., Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Ruixia Zhou, PhD, Scientific Review Officer, 6707 Democracy Boulevard, Democracy Two Building, Suite 957, Bethesda, MD 20892, 301-496-4773, zhour@mail.nih.gov.
Name of Committee: National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel; Tissue Engineering/Regenerative Medicine.
Date: March 20, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, Bethesda, MD 20814.
Contact Person: John K. Hayes, PhD, Scientific Review Officer, 6707 Democracy Boulevard, Democracy Two Building, Suite 959, Bethesda, MD 20892, 301-451-3398, hayesj@mail.nih.gov.
Name of Committee: National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel.
Date: March 20, 2009.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: Democracy Plaza II, 6707 Democracy Blvd., Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Ruixia Zhou, PhD, Scientific Review Officer, 6707 Democracy Boulevard, Democracy Two Building, Suite 957, Bethesda, MD 20892, 301-496-4773, zhour@mail.nih.gov.
Start SignatureDated: February 13, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-3711 Filed 2-20-09; 8:45 am]
BILLING CODE 4140-01-P
Document Information
- Effective Date:
- 3/19/2009
- Published:
- 02/23/2009
- Department:
- National Institutes of Health
- Entry Type:
- Notice
- Document Number:
- E9-3711
- Dates:
- March 19, 2009.
- Pages:
- 8099-8099 (1 pages)
- PDF File:
- e9-3711.pdf
- Supporting Documents:
- » License Agreements; Start-Up Exclusive Evaluation Option: Activators of Human Pyruvate Kinase to Treat Cancer
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: National Institute of Nursing Research
- » Meetings: National Institute of Allergy and Infectious Diseases
- » Meetings: National Eye Institute
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: Center for Scientific Review
- » Meetings: Center for Scientific Review
- » Meetings: National Institute of Environmental Health Sciences
- » Meetings: National Human Genome Research Institute